Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo

Circulation Research

Volumn 90, Issue 12, 2002, Pages 1325-1332

  Ahn, Jong Deok ^a   Morishita, Ryuichi ^a   Kaneda, Yasufumi ^a   Lee, Sang Jun ^a   Kwon, Ki Young ^a   Choi, Se Young ^a   Lee, Ki Up ^a   Park, Joong Yeol ^a   Moon, Ik Jae ^a   Park, Jong Gu ^a   Yoshizumi, Masao ^a   Ouchi, Yasuyoshi ^a   Lee, In Kyu ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

Activator protein 1; Dumbbell; HVJ liposome; Neointimal formation; Smooth muscle cell proliferation

Indexed keywords

CYCLIN A; CYCLINE; EXODEOXYRIBONUCLEASE III; GLUCOSE; LIPOSOME; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NORTHERN BLOTTING; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; RAT; RESTENOSIS; SERUM; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

ANGIOPLASTY, BALLOON; ANIMALS; BASE SEQUENCE; BINDING SITES; CAROTID STENOSIS; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DNA, CIRCULAR; DNA-BINDING PROTEINS; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 0037188929     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000023200.19316.D5     Document Type: Article

References (34)

1. Restenosis after coronary angioplasty
2. Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis
3. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
4. Intimal hyperplasia after vascular injury is inhibiter by antisense cdk 2 kinase oligonucleotides
5. In vivo transfection of cis element "decoy" against NF-κB binding site prevented myocardial infarction as gene therapy
6. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury
7. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries
8. 2-terminal kinase prevents neointimal formation in balloon-injured rat artery
9. The regulation of AP-1 activity by mitogen-activated protein kinases
10. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathway
11. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides
12. Role of AP-1 complex in angiotensin II-mediated transforming growth factor-β expression and growth of smooth muscle cells: Using decoy approach against AP-1 binding site
13. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFκB binding site
14. Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1
15. Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides
16. Phosphorothioate oligodeoxynucleotides are inhibitors of human DNA polymerases and Rnase H: Implications for antisense technology
17. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding
18. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism
19. The stability of different forms of double-stranded decoy DNA in serum and nuclear extracts
20. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides
21. Adenosine inhibits growth of human aortic smooth muscle cells via A2b receptors
22. Reactive oxygen and NF-κB in VEGF-induced migration of human vascular smooth muscle cells
23. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells
24. Down-regulation of the cyclin A promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclin AMP-responsive element-binding protein
25. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation
26. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury
27. Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro
28. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries
29. Transcriptional control of deformation-induced preproendothelin-1 gene expression in endothelial cells
30. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury
31. Enhanced expression of platelet derived growth factor-β receptor by high glucose involvement of platelet-derived growth factor in diabetic angiopathy
32. High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cell
33. The intima: Soil for atherosclerosis and restenosis
34. Role of basic fibroblast growth factor in vascular lesion formation